Severe COVID-19: what have we learned with the immunopathogenesis?

Adv Rheumatol. 2020 Sep 22;60(1):50. doi: 10.1186/s42358-020-00151-7.

Abstract

The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global major concern. In this review, we addressed a theoretical model on immunopathogenesis associated with severe COVID-19, based on the current literature of SARS-CoV-2 and other epidemic pathogenic coronaviruses, such as SARS and MERS. Several studies have suggested that immune dysregulation and hyperinflammatory response induced by SARS-CoV-2 are more involved in disease severity than the virus itself.Immune dysregulation due to COVID-19 is characterized by delayed and impaired interferon response, lymphocyte exhaustion and cytokine storm that ultimately lead to diffuse lung tissue damage and posterior thrombotic phenomena.Considering there is a lack of clinical evidence provided by randomized clinical trials, the knowledge about SARS-CoV-2 disease pathogenesis and immune response is a cornerstone to develop rationale-based clinical therapeutic strategies. In this narrative review, the authors aimed to describe the immunopathogenesis of severe forms of COVID-19.

Keywords: COVID-19; Cytokine; Cytokine storm; Immunology; Inflammation; Macrophage activation syndrome; SARS-CoV-2; Thrombosis.

Publication types

  • Systematic Review

MeSH terms

  • Age Factors
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Antibody Formation
  • Betacoronavirus / immunology*
  • Betacoronavirus / pathogenicity
  • Blood Coagulation Disorders / etiology
  • COVID-19
  • Comorbidity
  • Coronavirus Infections / blood
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology*
  • Cytokine Release Syndrome / immunology*
  • Humans
  • Immunity, Innate
  • Inflammation / immunology
  • Lung / pathology
  • Lymphopenia / immunology
  • Mice
  • Middle East Respiratory Syndrome Coronavirus / immunology
  • Pandemics
  • Peptidyl-Dipeptidase A / physiology
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology*
  • Respiratory Distress Syndrome / immunology*
  • Risk Factors
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / immunology
  • Severity of Illness Index
  • Sex Factors
  • Virus Internalization

Substances

  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, mouse
  • Angiotensin-Converting Enzyme 2